Discovery Labs Could Proceed with Surfaxin Program (DSCO)
Wed. September 30, 2009; Posted: 10:51 AM
Sep 30, 2009 (SmarTrend(R) News Watch via COMTEX) --
DSCO |
Quote |
Chart |
News |
PowerRating -- 9/30/2009 - Discovery Labs (NASDAQ:DSCO) said Wednesday that following talks with the Food and Drug Administration, it may be able to continue with its Surfaxin program. The FDA had delayed the respiratory drug for infants as it requested more information about the drug's shelf life. The company is confident that after the discussion it will be able to move forward, aiming for protocol FDA submission in the fourth quarter. Shares of DSCO moved 32.4% higher during early Wednesday trading.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
For full details on Discovery Labs Inc (DSCO)
click here. Discovery Labs Inc (DSCO) has Short Term PowerRatings of 5. Details on Discovery Labs Inc (DSCO) Short Term PowerRatings is available at
This Link.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index